Suppr超能文献

达比加群酯和利伐沙班对氧化胆固醇致血管内皮损伤模型中 DNA 氧化变化的保护作用。

The Protective Effect of Dabigatran and Rivaroxaban on DNA Oxidative Changes in a Model of Vascular Endothelial Damage with Oxidized Cholesterol.

机构信息

Laboratory of Tissue Immunopharmacology, Department of Internal Diseases and Clinical Pharmacology, Medical University of Lodz, Kniaziewicza 1/5, 91-347 Lodz, Poland.

Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.

出版信息

Int J Mol Sci. 2020 Mar 13;21(6):1953. doi: 10.3390/ijms21061953.

Abstract

BACKGROUND

Atherosclerotic plaques are unstable, and their release may result in thrombosis; therefore, currently, antiplatelet therapy with anticoagulants is recommended for the treatment of acute coronary syndrome. The aim of this study was to assess the effect of oxidized cholesterol on human umbilical vascular endothelial cells (HUVECs). The study also examines the protective and repairing effect of dabigatran and rivaroxaban in a model of vascular endothelial damage with 25-hydroxycholesterol (25-OHC).

METHODS

HUVECs were treated with compounds induce DNA single-strand breaks (SSBs) using the comet assay. Oxidative DNA damage was detected using endonuclease III (Nth) or human 8 oxoguanine DNA glycosylase (hOOG1). Reactive oxygen species (ROS) formation was determined using flow cytometry.

RESULTS

25-hydroxycholesterol caused DNA SSBs, induced oxidative damage and increased ROS in the HUVECs; ROS level was lowered by dabigatran and rivaroxaban. Only dabigatran was able to completely repair the DNA SSBs induced by oxysterol. Dabigatran was able to reduce the level of oxidative damage of pyrimidines induced by oxysterol to the level of control cells.

CONCLUSIONS

Observed changes strongly suggest that the tested anticoagulants induced indirect repair of DNA by inhibiting ROS production. Furthermore, dabigatran appears to have a higher antioxidant activity than rivaroxaban.

摘要

背景

动脉粥样硬化斑块不稳定,其释放可能导致血栓形成;因此,目前建议对急性冠脉综合征患者采用抗血小板治疗联合抗凝治疗。本研究旨在评估氧化胆固醇对人脐静脉内皮细胞(HUVEC)的影响。本研究还研究了达比加群酯和利伐沙班在 25-羟胆固醇(25-OHC)诱导的血管内皮损伤模型中的保护和修复作用。

方法

采用彗星试验检测化合物诱导 HUVEC 产生 DNA 单链断裂(SSB),用内切酶 III(Nth)或人 8-氧鸟嘌呤 DNA 糖基化酶(hOOG1)检测氧化 DNA 损伤。采用流式细胞术检测活性氧(ROS)的形成。

结果

25-羟胆固醇导致 HUVEC 产生 DNA SSB,诱导氧化损伤并增加 ROS;达比加群酯和利伐沙班降低 ROS 水平。只有达比加群酯能够完全修复由胆甾醇氧化物诱导的 DNA SSB。达比加群酯能够将胆甾醇氧化物诱导的嘧啶氧化损伤水平降低至对照细胞水平。

结论

观察到的变化强烈表明,所测试的抗凝剂通过抑制 ROS 产生诱导了 DNA 的间接修复。此外,达比加群酯的抗氧化活性似乎高于利伐沙班。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验